Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis

被引:45
作者
Dingli, D
Schwager, SM
Mesa, RA
Li, CY
Dewald, GW
Tefferi, A
机构
[1] Mayo Clin, Div Hematol, Coll Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Lab Med, Coll Med, Rochester, MN 55905 USA
关键词
myelofibrosis; polycythemia vera; essential thrombocythemia; chronic myeloproliferative disorders;
D O I
10.1002/cncr.21868
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Postpolycythemic (PV) and postthrombocythemic (FT) myeloid metaplasia are consensually referred to as secondary myelofibrosis (sMF). Prognostic variables in sMF are not as well defined as they are for de novo myelofibrosis with myeloid metaplasia (MMM), which is also known as agnogenic myeloid metaplasia (AMM). Such information is particularly crucial for management decisions in transplant-eligible patients. METHODS. Diagnoses of PV and ET required fulfillment of the World Health Organization criteria for the diagnosis of MMM as well as an antecedent history of either polycythemia vera or essential thrombocythemia that was supported by bone marrow examination. Cytogenetic findings were classified as being either favorable (normal or isolated 13q- or 20q- clones) or unfavorable (presence of abnormalities other than 13q- and 20q-). RESULTS. The study population was comprised of 66 young patients (age < 60 yrs) With sMF, including 37 patients with PV and 29 patients with ET. Multivariate analysis of parameters other than cytogenetics identified older age (P = .02), anemia (hemoglobin level < 10 g/dL [P = .007]), and PV (P = .009) to be independent risk factors for shortened survival. However, when such analysis was restricted to patients in whom cytogenetic studies were performed (n = 31 patients), the presence of unfavorable cytogenetic abnormalities (i.e., clones other than 20q- and 13q-) became the only adverse prognostic factor for survival (P = .001). A similar analysis in a temporal cohort of 50 age-matched patients with AMM also identified unfavorable cytogenetics as an independent predictor of poor Survival, along with thrombocytopenia and anemia. CONCLUSIONS. The results of the current study suggest that cytogenetic findings might supersede AMM-derived prognostic scoring systems for predicting survival in patients with sMF.
引用
收藏
页码:1985 / 1989
页数:5
相关论文
共 22 条
[1]   The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia [J].
Barosi, G ;
Ambrosetti, A ;
Finelli, C ;
Grossi, A ;
Leoni, P ;
Liberato, NL ;
Petti, MC ;
Pogliani, E ;
Ricetti, M ;
Rupoli, S ;
Visani, G ;
Tura, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) :730-737
[2]   Myelofibrosis with myeloid metaplasia following essential thrombocythaemia:: actuarial probability, presenting characteristics and evolution in a series of 195 patients [J].
Cervantes, F ;
Alvarez-Larrán, A ;
Talarn, C ;
Gómez, M ;
Montserrat, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) :786-790
[3]   Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups [J].
Cervantes, F ;
Barosi, G ;
Demory, JL ;
Reilly, J ;
Guarnone, R ;
Dupriez, B ;
Pereira, A ;
Montserrat, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) :684-690
[4]   Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis [J].
Cervantes, F ;
Pereira, A ;
Esteve, J ;
Rafel, M ;
Cobo, F ;
Rozman, C ;
Montserrat, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) :635-640
[5]  
DEMORY JL, 1988, BLOOD, V72, P855
[6]   Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia - A simple CBC-based scoring system [J].
Dingli, D ;
Schwager, SM ;
Mesa, RA ;
Li, CY ;
Tefferi, A .
CANCER, 2006, 106 (03) :623-630
[7]  
Dupriez B, 1996, BLOOD, V88, P1013
[8]  
Jaffe E.S., 2001, PATHOLOGY GENETICS T, V3
[9]   TREATMENT OF PRIMARY PROLIFERATIVE POLYCYTHEMIA BY VENESECTION AND LOW-DOSE BUSULFAN - RETROSPECTIVE STUDY FROM ONE CENTER [J].
MESSINEZY, M ;
PEARSON, TC ;
PROCHAZKA, A ;
WETHERLEYMEIN, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (04) :657-666
[10]   POLYCYTHEMIA-VERA IN YOUNG-PEOPLE - AN ANALYSIS OF 58 CASES DIAGNOSED BEFORE 40 YEARS [J].
NAJEAN, Y ;
MUGNIER, P ;
DRESCH, C ;
RAIN, JD .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (03) :285-291